NCT01385696View on ClinicalTrials.gov

Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DEVICE

Genuair® (Almirall S.A.)

Inhaler with only placebo, once daily, 14 days

DEVICE

HandiHaler® (Boehringer Ingelheim's)

Inhaler with only placebo, once daily, 14 days

Trial Locations (4)

53119

Almirall investigative site 3, Bonn

56068

Almirall investigative site 5, Koblenz

7511 JX

Almirall investigative site 1, Enschede

7207 AE

Almirall investigative site 2, Zutphen

Sponsors

Lead Sponsor

Almirall, S.A.
All Listed Sponsors
lead

Almirall, S.A.

INDUSTRY